1. Home
  2. KOD vs STRS Comparison

KOD vs STRS Comparison

Compare KOD & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOD
  • STRS
  • Stock Information
  • Founded
  • KOD 2009
  • STRS 1992
  • Country
  • KOD United States
  • STRS United States
  • Employees
  • KOD N/A
  • STRS N/A
  • Industry
  • KOD Biotechnology: Biological Products (No Diagnostic Substances)
  • STRS Homebuilding
  • Sector
  • KOD Health Care
  • STRS Real Estate
  • Exchange
  • KOD Nasdaq
  • STRS Nasdaq
  • Market Cap
  • KOD 188.9M
  • STRS 155.7M
  • IPO Year
  • KOD 2018
  • STRS N/A
  • Fundamental
  • Price
  • KOD $3.62
  • STRS $19.56
  • Analyst Decision
  • KOD Hold
  • STRS
  • Analyst Count
  • KOD 3
  • STRS 0
  • Target Price
  • KOD $9.00
  • STRS N/A
  • AVG Volume (30 Days)
  • KOD 294.1K
  • STRS 7.4K
  • Earning Date
  • KOD 08-13-2025
  • STRS 08-12-2025
  • Dividend Yield
  • KOD N/A
  • STRS N/A
  • EPS Growth
  • KOD N/A
  • STRS N/A
  • EPS
  • KOD N/A
  • STRS N/A
  • Revenue
  • KOD N/A
  • STRS $32,719,000.00
  • Revenue This Year
  • KOD N/A
  • STRS N/A
  • Revenue Next Year
  • KOD N/A
  • STRS N/A
  • P/E Ratio
  • KOD N/A
  • STRS N/A
  • Revenue Growth
  • KOD N/A
  • STRS N/A
  • 52 Week Low
  • KOD $1.92
  • STRS $15.10
  • 52 Week High
  • KOD $11.60
  • STRS $30.66
  • Technical
  • Relative Strength Index (RSI)
  • KOD 46.82
  • STRS 55.17
  • Support Level
  • KOD $3.52
  • STRS $18.20
  • Resistance Level
  • KOD $3.78
  • STRS $19.95
  • Average True Range (ATR)
  • KOD 0.35
  • STRS 1.06
  • MACD
  • KOD -0.05
  • STRS -0.01
  • Stochastic Oscillator
  • KOD 30.77
  • STRS 88.63

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.

Share on Social Networks: